A novel AI-derived digital biomarker for monitoring disease progression in ATTR-CM: first-in-trial use of a computer vision AI-ECG algorithm within a phase 3 pivotal randomized controlled trial
31 August 2026 (11:15 - 12:00)
Organised by: 
About the speaker
Yale School of Medicine, New Haven (United States of America)
3 More presentations in this session
Doctor M. Hall (Leeds, GB)
Assistant Professor F. Tjong (Amsterdam, NL)
Access the full session
The Event
ESC Congress 2026
31 August 2026
11:15 CET
You may be interested in
Congress Presentation
Congress Presentation
Congress Presentation
Congress Presentation
